Serum 25-hydroxyvitamin D predicts cognitive performance in adults

Hala Darwish, Pia Zeinoun, Husam Ghusn, Brigitte Khoury, Hani Tamim, Samia J Khoury, Hala Darwish, Pia Zeinoun, Husam Ghusn, Brigitte Khoury, Hani Tamim, Samia J Khoury

Abstract

Background: Vitamin D is an endogenous hormone known to regulate calcium levels in the body and plays a role in cognitive performance. Studies have shown an association between vitamin D deficiency and cognitive impairment in older adults. Lebanon has a high 25-hydroxyvitamin D (25(OH)D) deficiency prevalence across all age groups.

Methods: In this cross-sectional study, we explored the cognitive performance and serum 25(OH)D levels using an electrochemoluminescent immunoassay in 254 older (>60 years) as well as younger (30-60 years) adults. Subjects' characteristics, including age, years of education, wearing of veil, alcohol consumption, smoking, and physical exercise, were collected. Participants were screened for depression prior to cognitive screening using the Montreal Cognitive Assessment Arabic version. Visuospatial memory was tested using the Rey Complex Figure Test and Recognition Trial, and speed of processing was assessed using the Symbol Digit Modalities test.

Results: Pearson's correlation and stepwise linear regression analyses showed that a low vitamin D level was associated with greater risk of cognitive impairment in older as well as younger adults.

Conclusion: These findings suggest that correction of vitamin D needs to be explored as an intervention to prevent cognitive impairment. Prospective longitudinal studies are needed to ascertain the effect of such interventions.

Keywords: aging; cognitive function; neuro-psychological function.

Figures

Figure 1
Figure 1
Sample characteristics: years of education.

References

    1. Arabi A, Baddoura R, Awada H, Salamoun M, Ayoub G, El-Hajj Fuleihan G. Hypovitaminosis D osteopathy: is it mediated through PTH, lean mass, or is it a direct effect? Bone. 2006;39(2):268–275.
    1. Dawson-Hughes B. Serum 25-hydroxyvitamin D and functional outcomes in the elderly. Am J Clin Nutr. 2008;88(2):537S–540S.
    1. Sutherland MK, Somerville MJ, Yoong LK, Bergeron C, Haussler MR, McLachlan DR. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res. 1992;13(3):239–250.
    1. Langub MC, Herman JP, Malluche HH, Koszewski NJ. Evidence of functional vitamin D receptors in rat hippocampus. Neuroscience. 2001;104(1):49–56.
    1. Llewellyn DJ, Lang IA, Langa KM, Melzer D. Vitamin D and cognitive impairment in the elderly U.S. population. J Gerontol A Biol Sci Med Sci. 2011;66(1):59–65.
    1. Littlejohns TJ, Henley WE, Lang IA, et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology. 2014;83(10):920–928.
    1. Granic A, Hill TR, Kirkwood TB, et al. Serum 25-hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ Study. Eur J Neurol. 2015;22(1):106–15. e6.
    1. Toffanello ED, Coin A, Perissinotto E, et al. Vitamin D deficiency predicts cognitive decline in older men and women: The Pro.V.A. Study. Neurology. 2014;83(24):2292–2298.
    1. Nagel G, Herbolsheimer F, Riepe M, et al. ActiFE Study Group Serum vitamin D concentrations and cognitive function in a population-based study among older adults in south Germany. J Alzheimers Dis. 2015;45(4):1119–1126.
    1. Maddock J, Cavadino A, Power C, Hyppönen E. 25-hydroxyvitamin D, APOE ε4 genotype and cognitive function: findings from the 1958 British birth cohort. Eur J Clin Nutr. 2015;69(4):505–508.
    1. Lee DM, Tajar A, Ulubaev A, et al. EMAS study group Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry. 2009;80(7):722–729.
    1. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S–1086S.
    1. US Department of Agriculture; US Department of Health and Human Services . Dietary Guidelines for Americans, 2010. 7th ed. Washington, DC: US Government Printing Office; 2010.
    1. Centers for Disease Control and Prevention (CDC) Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2009. Available from .
    1. Sabia S, Elbaz A, Britton A, et al. Alcohol consumption and cognitive decline in early old age. Neurology. 2014;82(4):332–339.
    1. Schneeweis N, Skirbekk V, Winter-Ebmer R. Does education improve cognitive performance four decades after school completion? Demography. 2014;51(2):619–643.
    1. Snowden M, Steinman L, Mochan K, et al. Effect of exercise on cognitive performance in community-dwelling older adults: review of intervention trials and recommendations for public health practice and research. J Am Geriatr Soc. 2011;59(4):704–716.
    1. Evans VC, Iverson GL, Yatham LN, Lam RW. The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review. J Clin Psychiatry. 2014;75(12):1359–1370.
    1. Mahfoud Z, Kobeissi L, Peters TJ, Araya R, Ghantous Z, Khoury B. The Arabic validation of Hopkins Symptoms Checklist-25 against MINI in a disadvantaged suburb of Beirut, Lebanon. The International Journal of Educational and Psychological Assessment (TIJEPA) 2013;13(1):17–33.
    1. Mahfoud Z, Abdulrahim S, Taha MB, et al. Validation of the Arab Youth Mental Health scale as a screening tool for depression/anxiety in Lebanese children. Child Adolesc Psychiatry Ment Health. 2011;5:9.
    1. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19(1):1–15.
    1. Kleijn WC, Hovens JE, Rodenburg JJ. Posttraumatic stress symptoms in refugees: assessments with the Harvard Trauma Questionnaire and the Hopkins symptom Checklist-25 in different languages. Psychol Rep. 2001;88(2):527–532.
    1. Rahman TT, El Gaafary MM. Montreal Cognitive Assessment Arabic version: reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. Geriatr Gerontol Int. 2009;9(1):54–61.
    1. Fastenau PS, Denburg NL, Hufford BJ. Adult norms for the Rey-Osterrieth Complex Figure Test and for supplemental recognition and matching trials from the Extended Complex Figure Test. Clin Neuropsychol. 1999;13(1):30–47.
    1. Schwarz L, Penna S, Novack T. Factors contributing to performance on the Rey Complex Figure Test in individuals with traumatic brain injury. Clin Neuropsychol. 2009;23(2):255–267.
    1. Cores EV, Vanotti S, Eizaguirre B, et al. The effect of culture on two information-processing speed tests. Appl Neuropsychol Adult. 2015;22(4):241–245.
    1. Maalouf J, Nabulsi M, Vieth R, et al. Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children. J Clin Endocrinol Metab. 2008;93(7):2693–2701.
    1. Davis BJ, Vidal JS, Garcia M, et al. The alcohol paradox: light- to-moderate alcohol consumption, cognitive function, and brain volume. J Gerontol A Biol Sci Med Sci. 2014;69(12):1528–1535.
    1. Brouwer-Brolsma EM, de Groot LC. Vitamin D and cognition in older adults: an update of recent findings. Curr Opin Clin Nutr Metab Care. 2015;18(1):11–16.
    1. Etgen T, Sander D, Bickel H, Sander K, Förstl H. Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis. Dement Geriatr Cogn Disord. 2012;33(5):297–305.
    1. Wilson VK, Houston DK, Kilpatrick L, et al. Health, Aging and Body Composition Study Relationship between 25-hydroxyvitamin D and cognitive function in older adults: the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2014;62(4):636–641.
    1. Perna L, Mons U, Kliegel M, Brenner H. Serum 25-hydroxyvitamin D and cognitive decline: a longitudinal study among non-demented older adults. Dement Geriatr Cogn Disord. 2014;38(3–4):254–263.
    1. Hoteit M, Al-Shaar L, Yazbeck C, Bou Sleiman M, Ghalayini T, Fuleihan Gel-H. Hypovitaminosis D in a sunny country: time trends, predictors, and implications for practice guidelines. Metabolism. 2014;63(7):968–978.
    1. El-Hajj Fuleihan G, Bouillon R, Clarke B, et al. Serum 25-hydroxyvitamin D levels: variability, knowledge gaps, and the concept of a desirable range. J Bone Miner Res. 2015;30(7):1119–1133.
    1. Subirana-Mirete J, Bruna O, Virgili C, Signo S, Palma C. Processing speed in the aging process: screening criteria for the Spanish Quick Test of Cognitive Speed. Percept Mot Skills. 2014;119(2):417–429.
    1. Annweiler C, Maby E, Meyerber M, Beauchet O. Hypovitaminosis D and executive dysfunction in older adults with memory complaint: a memory clinic-based study. Dement Geriatr Cogn Disord. 2014;37(5–6):286–293.
    1. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A. Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci. 2002;22:443–447.
    1. Nocentini U, Giordano A, Di Vincenzo S, Panella M, Pasqualetti P. The Symbol Digit Modalities Test - Oral version: Italian normative data. Functional Neurology. 2006;21(2):93–96.
    1. Nabulsi M, Mahfoud Z, Maalouf J, Arabi A, Fuleihan GE. Impact of maternal veiling during pregnancy and socioeconomic status on offspring’s musculoskeletal health. Osteoporos Int. 2008;19(3):295–302.
    1. Ganguli M, Vander Bilt J, Saxton JA, Shen C, Dodge HH. Alcohol consumption and cognitive function in late life: a longitudinal community study. Neurology. 2005;65(8):1210–1217.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する